
From the U.S. Code Online via GPO Access
[wais.access.gpo.gov]
[Laws in effect as of January 2, 2001]
[Document not affected by Public Laws enacted between
  January 2, 2001 and January 28, 2002]
[CITE: 21USC1701]

 
                        TITLE 21--FOOD AND DRUGS
 
                CHAPTER 22--NATIONAL DRUG CONTROL POLICY
 
Sec. 1701. Definitions

    In this chapter:

                        (1) Demand reduction

        The term ``demand reduction'' means any activity conducted by a 
    National Drug Control Program agency, other than an enforcement 
    activity, that is intended to reduce the use of drugs, including--
            (A) drug abuse education;
            (B) drug abuse prevention;
            (C) drug abuse treatment;
            (D) drug abuse research;
            (E) drug abuse rehabilitation;
            (F) drug-free workplace programs; and
            (G) drug testing.

                            (2) Director

        The term ``Director'' means the Director of National Drug 
    Control Policy.

                              (3) Drug

        The term ``drug'' has the meaning given the term ``controlled 
    substance'' in section 802(6) of this title.

                          (4) Drug control

        The term ``drug control'' means any activity conducted by a 
    National Drug Control Program agency involving supply reduction or 
    demand reduction.

                              (5) Fund

        The term ``Fund'' means the fund established under section 
    1702(d) of this title.

                  (6) National Drug Control Program

        The term ``National Drug Control Program'' means programs, 
    policies, and activities undertaken by National Drug Control Program 
    agencies pursuant to the responsibilities of such agencies under the 
    National Drug Control Strategy.

              (7) National Drug Control Program agency

        The term ``National Drug Control Program agency'' means any 
    agency that is responsible for implementing any aspect of the 
    National Drug Control Strategy, including any agency that receives 
    Federal funds to implement any aspect of the National Drug Control 
    Strategy, but does not include any agency that receives funds for 
    drug control activity solely under the National Foreign Intelligence 
    Program, the Joint Military Intelligence Program or Tactical 
    Intelligence and Related Activities, unless such agency has been 
    designated--
            (A) by the President; or
            (B) jointly by the Director and the head of the agency.

                 (8) National Drug Control Strategy

        The term ``National Drug Control Strategy'' means the strategy 
    developed and submitted to Congress under section 1705 of this 
    title.

                             (9) Office

        Unless the context clearly implicates otherwise, the term 
    ``Office'' means the Office of National Drug Control Policy 
    established under section 1702(a) of this title.

                    (10) State and local affairs

        The term ``State and local affairs'' means domestic activities 
    conducted by a National Drug Control Program agency that are 
    intended to reduce the availability and use of drugs, including--
            (A) coordination and facilitation of Federal, State, and 
        local law enforcement drug control efforts;
            (B) promotion of coordination and cooperation among the drug 
        supply reduction and demand reduction agencies of the various 
        States, territories, and units of local government; and
            (C) such other cooperative governmental activities which 
        promote a comprehensive approach to drug control at the 
        national, State, territory, and local levels.

                        (11) Supply reduction

        The term ``supply reduction'' means any activity of a program 
    conducted by a National Drug Control Program agency that is intended 
    to reduce the availability or use of drugs in the United States and 
    abroad, including--
            (A) international drug control;
            (B) foreign and domestic drug intelligence;
            (C) interdiction; and
            (D) domestic drug law enforcement, including law enforcement 
        directed at drug users.

(Pub. L. 105-277, div. C, title VII, Sec. 702, Oct. 21, 1998, 112 Stat. 
2681-670.)

                            Repeal of Section

        For repeal of section on Sept. 30, 2003, see section 1712 of 
    this title.

                       References in Text

    This chapter, referred to in text, was in the original ``this 
title'', meaning title VII of div. C of Pub. L. 105-277, Oct. 21, 1998, 
112 Stat. 2681-670, known as Office of National Drug Control Policy 
Reauthorization Act of 1998, which is classified principally to this 
chapter. For complete classification of title VII to the Code, see Short 
Title note set out below and Tables.


                               Short Title

    Pub. L. 105-277, div. C, title VII, Sec. 701, Oct. 21, 1998, 112 
Stat. 2681-670, provided that: ``This title [enacting this chapter, 
amending section 1509 of this title, sections 5312 to 5314 of Title 5, 
Government Organization and Employees, section 1105 of Title 31, Money 
and Finance, and section 402 of Title 50, War and National Defense] may 
be cited as the `Office of National Drug Control Policy Reauthorization 
Act of 1998'.''

  Ex. Ord. No. 13165. White House Task Force on Drug Use in Sports and 
   United States Representative on the Board of the World Anti-Doping 
                                 Agency

    Ex. Ord. No. 13165, Aug. 9, 2000, 65 F.R. 49469, provided:
    By the authority vested in me as President by the Constitution and 
the laws of the United States of America, including the Office of 
National Drug Control [Policy] Reauthorization Act of 1998, (21 U.S.C. 
1701 et seq.), and in order to develop recommendations for Federal 
agency actions to address the use of drugs in sports, in particular 
among young people, it is hereby ordered as follows:
    Section 1. Policy. The use of drugs in sports has reached a level 
that endangers not just the legitimacy of athletic competition but also 
the lives and health of athletes--from the elite ranks to youth leagues. 
The National Household Survey on Drug Abuse issued in 1999 found that in 
just 1 year's time the rate of steroid use among young people rose 
roughly 50 percent among both sexes and across all age groups. It is the 
policy of my Administration to take the steps needed to help eliminate 
illicit or otherwise banned drug use and doping in sports at the State, 
national, and international level.
    Sec. 2. Establishment of a White House Task Force on Drug Use in 
Sports. (a) There is established a White House Task Force on Drug Use in 
Sports (Task Force). The Task Force shall comprise the co-vice chairs of 
the White House Olympic Task Force (the ``Olympic Task Force Vice 
Chairs''), and representatives designated by the Office of National Drug 
Control Policy, the Department of Health and Human Services, the 
Department of Labor, the President's Council on Physical Fitness and 
Sports, the Office of Management and Budget, the National Security 
Council, the Department of State, the Department of the Treasury, the 
Department of Education, the Department of Justice, the Department of 
Transportation, the National Institute on Drug Abuse, and the Substance 
Abuse and Mental Health Services Administration.
    (b) The Task Force shall develop recommendations for the President 
on further executive and legislative actions that can be undertaken to 
address the problem of doping and drug use in sports. In developing the 
recommendations, the Task Force shall consider, among other things: (i) 
the health and safety of America's athletes, in particular our Nation's 
young people; (ii) the integrity of honest athletic competition; and 
(iii) the views and recommendations of State and local governments, the 
private sector, citizens, community groups, and nonprofit organizations, 
on actions to address this threat. The Task Force, through its Chairs, 
shall submit its recommendations to the President.
    (c) The Director of the Office of National Drug Control Policy (the 
Director), the Secretary of the Department of Health and Human Services, 
and the Olympic Task Force Vice Chairs or their designees shall serve as 
the Task Force Chairs.
    (d) To the extent permitted by law and at the request of the Chairs, 
agencies shall cooperate with and provide information to the Task Force.
    Sec. 3. Participation in the World Anti-Doping Agency. (a) As part 
of my Administration's efforts to address the problem of drug use in 
sports, the United States has played a leading role in the formation of 
a World Anti-Doping Agency (WADA) by the Olympic and sports community 
and the nations of the world. Through these efforts, the United States 
has been selected to serve as a governmental representative on the board 
of the WADA. This order will authorize the Director to serve as the 
United States Government's representative on the WADA board.
    (b) Pursuant to 21 U.S.C. 1701 et seq., the Director, or in his 
absence his designee, is hereby authorized to take all necessary and 
proper actions to execute his responsibilities as United States 
representative to the WADA.
    (c) To assist the Director in carrying out these responsibilities as 
the United States Government representative to the WADA and to the 
extent permitted by law, Federal employees may serve in their official 
capacity, inter alia, on WADA Committees or WADA advisory committees, 
serving as experts to the WADA.
                                                     William J. Clinton.

                  Section Referred to in Other Sections

    This section is referred to in section 1702 of this title.
